These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37816184)

  • 1. Evaluation of Compounded Transdermal Analgesic Formulations Using the Franz Finite Dose Model.
    Baneshi M; Tyagi D; Panneerselvam E; MacKenzie G; Coleman J; Zhang SX
    Int J Pharm Compd; 2023; 27(5):424-430. PubMed ID: 37816184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the Percutaneous Absorption of Ketamine HCl, Gabapentin, Clonidine HCl, and Baclofen, in Compounded Transdermal Pain Formulations, Using the Franz Finite Dose Model.
    Bassani AS; Banov D
    Pain Med; 2016 Feb; 17(2):230-8. PubMed ID: 26352507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin permeation and antinociception of topical gabapentin formulations.
    Bryson E; Asbill S; Sweitzer S
    Int J Pharm Compd; 2014; 18(6):504-11. PubMed ID: 25906628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin Permeation and Antinociception of Compounded Topical Cyclobenzaprine Hydrochloride Formulations.
    Bryson E; Hartman R; Arnold J; Gorman G; Sweitzer S; Asbill S
    Int J Pharm Compd; 2015; 19(2):161-6. PubMed ID: 26685496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compounded Topical Gabapentin for Neuropathic Pain: Does Choice of Base Affect Efficacy?
    Shakshuki A; Agu RU
    Int J Pharm Compd; 2019; 23(6):496-503. PubMed ID: 31751946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compounded Topical Amitriptyline for Neuropathic Pain: In Vitro Release from Compounding Bases and Potential Correlation with Clinical Efficacy.
    Shakshuki A; Yeung P; Agu RU
    Can J Hosp Pharm; 2020; 73(2):133-140. PubMed ID: 32362670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the Percutaneous Absorption of Ketoprofen Using the Franz Skin Finite Dose Model.
    Bassani AS; Banov D; Phan H
    Postgrad Med; 2016; 128(2):262-7. PubMed ID: 26788899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the chemical and physical stability of ketoprofen compounded in various pharmaceutical bases on its topical and transdermal delivery.
    Nornoo AO; Wulz J; Yoon H; Nan Y; Lese M
    Pharm Dev Technol; 2016 Mar; 21(2):204-13. PubMed ID: 25431959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gabapentin in Elastic Liposomes: Preparation, Characterization, Drug Release, and Penetration Through Porcine Skin.
    Le UM; Baltzley S; AlGhananeem A
    Int J Pharm Compd; 2018; 22(6):498-503. PubMed ID: 30384350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and Application of a High-Performance Liquid Chromatography Stability-Indicating Assay for Beyond-Use Date Determination of Compounded Topical Gels Containing Multiple Active Drugs.
    Gorman G; Sokom S; Coward L; Arnold JJ
    Int J Pharm Compd; 2017; 21(2):164-170. PubMed ID: 28346213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Transdermal Drug Permeation as Modulated by Lipoderm and Pluronic Lecithin Organogel.
    Zhang Q; Song Y; Page SW; Garg S
    J Pharm Sci; 2018 Feb; 107(2):587-594. PubMed ID: 28935590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analgesic Efficacy and Transdermal Penetration of Topical Gabapentin Creams: Finding an Optimal Dose and Pre-treatment Time.
    Heustess A; Spigener S; Sweitzer S; Romero-Sandoval A; Asbill S
    Int J Pharm Compd; 2015; 19(2):167-73. PubMed ID: 26685497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and Evaluation of Topical Gabapentin Formulations.
    Martin CJ; Alcock N; Hiom S; Birchall JC
    Pharmaceutics; 2017 Aug; 9(3):. PubMed ID: 28867811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ex vivo percutaneous absorption of ketamine, bupivacaine, diclofenac, gabapentin, orphenadrine, and pentoxifylline: comparison of versatile cream vs. reference cream.
    Wang X; Black L
    Int J Pharm Compd; 2013; 17(6):520-5. PubMed ID: 24579304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous analgesia after transdermal application of amitriptyline versus lidocaine in rats.
    Haderer A; Gerner P; Kao G; Srinivasa V; Wang GK
    Anesth Analg; 2003 Jun; 96(6):1707-1710. PubMed ID: 12761001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transdermal behaviors comparisons among Evodia rutaecarpa extracts with different purity of evodiamine and rutaecarpine and the effect of topical formulation in vivo.
    Chen F; Li S; Li D; Ding JS
    Fitoterapia; 2012 Jul; 83(5):954-60. PubMed ID: 22565145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Penetration Enhancers on the Percutaneous Delivery of Pain Management Actives.
    Trimble J; Light B
    Int J Pharm Compd; 2016; 20(3):250-256. PubMed ID: 28333667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dermal delivery of amitriptyline for topical analgesia.
    Kung CP; Sil BC; Zhang Y; Hadgraft J; Lane ME; Patel B; McCulloch R
    Drug Deliv Transl Res; 2022 Apr; 12(4):805-815. PubMed ID: 33886076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of chronic neuropathic pain with single and compounded topical analgesics.
    Knezevic NN; Tverdohleb T; Nikibin F; Knezevic I; Candido KD
    Pain Manag; 2017 Nov; 7(6):537-558. PubMed ID: 29125423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged cutaneous analgesia with transdermal application of amitriptyline and capsaicin.
    Colvin AC; Wang CF; Soens MA; Mitani AA; Strichartz G; Gerner P
    Reg Anesth Pain Med; 2011; 36(3):236-40. PubMed ID: 21364497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.